The World Health Organization releases the first policy brief on TB-associated disability, presenting the current perspectives on the issue and approaches to mitigating the impact of these disabilities on health-related quality of life.

Investment in a new TB vaccine is a landmark step forward, but continued efforts to advance treatments, diagnostics and biosocial issues are needed to meet targets to end the epidemic by 2035.

Tuberculosis (TB) is an ancient disease impacting modern cities in 2023, such as London, England. 

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

The South African government and pharmaceutical company Johnson & Johnson (J&J) have agreed to a lower price for bedaquiline, a medicine used to treat drug-resistant tuberculosis (DR-TB) in South Africa.

A call to action ahead of the Union Conference urges France to confirm the commitments made in the UN Political Declaration on TB and to translate it into concrete measures.

Following the outcomes of the United Nations General Assembly’s second high-level meeting (UNHLM) on tuberculosis (TB) on September 22, APOPO is committed to redefining strategies for TB diagnosis.

There was a low risk for post-treatment recurrence among patients who received treatment for multidrug- or rifampicin-resistant tuberculosis infection.

On 24 October 2023, TB Europe Coalition hosted a webinar on sharing experiences on pilot data collection for four World Health Organization (WHO) indicators for the European region to measure the level of engagement of communities and civil society organizations in the national TB responses in the region.

Indonesia is still struggling to fight tuberculosis (TB), with the second-highest number of cases worldwide.